How to use NATCO Gefitinib

Gefitinib's mechanism of action is mainly to inhibit EGFR autophosphorylation, and block conduction, inhibit the proliferation of tumor cells, and achieve targeted therapy. Gefitinib is mainly used for locally advanced or metastatic non-small cell lung cancer that has received chemotherapy in the past, especially for lung adenocarcinoma. Today, let’s take a closer look at how to take NATCO Gefitinib in India.

Gefitinib administration method: 250mg daily, once a day, orally, on an empty stomach or with food. If you have difficulty swallowing, you can put the tablet into boiled water, stir for 10 minutes, drink the liquid immediately, rinse the cup with half a cup of water and drink it. It can also be administered via a nasal or gastric tube. There is no need to adjust the drug dosage due to age, weight, gender, race, kidney function or liver function. When there is intolerable diarrhea or skin adverse reactions, the drug can be temporarily stopped (up to 14 days).
　
Gefitinib is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that can target the growth of tumor cells and inhibit tumor angiogenesis. Gefitinib mainly targets non-small cell lung cancer, locally advanced or metastatic non-small cell lung cancer that has received chemotherapy in the past. Through its treatment, patients with non-small cell lung cancer can be controlled and even help patients prolong their lives.

India Natco is a leading global pharmaceutical company headquartered in Hyderabad, India. Natco is committed to creating a corporate culture of equal opportunities for everyone. Its core values ​​include: integrity and high ethical standards; respect for individuality and encourage diversity; openness, honesty, mutual trust and mutual support.

Gefitinib works well without any doubt. Gefitinib is an inhibitor of tyrosine kinase activity, which transduces programmed apoptosis of tumor cells by blocking downstream signaling pathways. Gefitinib significantly reduces solid tumors and significantly improves the subjective and objective symptoms and signs of patients. Gefitinib is an innovative drug with new therapies, new formulations, changes in traditional treatment methods, and improved quality of life. Gefitinib has mild side effects, is well tolerated, and is easy to take orally.

Gefitinib tablets are targeted drugs for the treatment of gene mutations in lung adenocarcinoma. As long as there is no resistance to this drug, you can continue to take it.